Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-06-17

FDA Approved: RISPERIDONE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals NY LLC's original ANDA for risperidone, authorizing a generic version of the antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

ORIG AP for RISPERIDONE (RISPERIDONE)